RIPK1 and amyotrophic lateral sclerosis: Treatment with primidone delayed the onset and progression of motor deficits, histological pathology and body-weight loss of SODG93A mice, an ALS model, validating the effect of primidone to inhibit RIPK1 and rescue motor functions in vivo.